Literature DB >> 24374484

The structural comparison between membrane-associated human carbonic anhydrases provides insights into drug design of selective inhibitors.

Vincenzo Alterio1, Peiwen Pan, Seppo Parkkila, Martina Buonanno, Claudiu T Supuran, Simona M Monti, Giuseppina De Simone.   

Abstract

Carbonic anhydrase isoform XIV (CA XIV) is the last member of the human (h) CA family discovered so far, being localized in brain, kidneys, colon, small intestine, urinary bladder, liver, and spinal cord. It has recently been described as a possible drug target for treatment of epilepsy, some retinopathies as well as some skin tumors. Human carbonic anhydrase (hCA) XIV is a membrane-associated protein consisting of an N-terminal extracellular domain, a putative transmembrane region, and a small cytoplasmic tail. In this article, we report the expression, purification, and the crystallographic structure of the entire extracellular domain of this enzyme. The analysis of the structure revealed the typical α-CA fold, in which a 10-stranded β-sheet forms the core of the molecule, while the comparison with all the other membrane associated isoforms (hCAs IV, IX, and XII) allowed to identify the diverse oligomeric arrangement and the sequence and structural differences observed in the region 127-136 as the main factors to consider in the design of selective inhibitors for each one of the membrane associated α-CAs.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  X-ray crystallography; carbonic anhydrase; drug design; inhibitors

Mesh:

Substances:

Year:  2014        PMID: 24374484     DOI: 10.1002/bip.22456

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  11 in total

Review 1.  Post-translational modifications in tumor-associated carbonic anhydrases.

Authors:  Anna Di Fiore; Claudiu T Supuran; Andrea Scaloni; Giuseppina De Simone
Journal:  Amino Acids       Date:  2021-08-26       Impact factor: 3.520

2.  The production and biochemical characterization of α-carbonic anhydrase from Lactobacillus rhamnosus GG.

Authors:  Linda J Urbański; Silvia Bua; Andrea Angeli; Reza Zolfaghari Emameh; Harlan R Barker; Marianne Kuuslahti; Vesa P Hytönen; Seppo Parkkila; Claudiu T Supuran
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-25       Impact factor: 5.560

3.  Binding of carbonic anhydrase IX to 45S rDNA genes is prevented by exportin-1 in hypoxic cells.

Authors:  Emanuele Sasso; Monica Vitale; Francesca Monteleone; Francesca Ludovica Boffo; Margherita Santoriello; Daniela Sarnataro; Corrado Garbi; Mariangela Sabatella; Bianca Crifò; Luca Alfredo Paolella; Giuseppina Minopoli; Jean-Yves Winum; Nicola Zambrano
Journal:  Biomed Res Int       Date:  2015-02-22       Impact factor: 3.411

4.  Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids.

Authors:  Grazia Luisi; Guido Angelini; Carla Gasbarri; Antonio Laghezza; Mariangela Agamennone; Fulvio Loiodice; Claudiu T Supuran; Cristina Campestre; Paolo Tortorella
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

Review 5.  Human carbonic anhydrases and post-translational modifications: a hidden world possibly affecting protein properties and functions.

Authors:  Anna Di Fiore; Claudiu T Supuran; Andrea Scaloni; Giuseppina De Simone
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

6.  Exploration of the residues modulating the catalytic features of human carbonic anhydrase XIII by a site-specific mutagenesis approach.

Authors:  Giuseppina De Simone; Anna Di Fiore; Emanuela Truppo; Emma Langella; Daniela Vullo; Claudiu T Supuran; Simona Maria Monti
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 7.  Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.

Authors:  Alessio Nocentini; Andrea Angeli; Fabrizio Carta; Jean-Yves Winum; Raivis Zalubovskis; Simone Carradori; Clemente Capasso; William A Donald; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

Review 8.  Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives.

Authors:  Lidia Ciccone; Chiara Cerri; Susanna Nencetti; Elisabetta Orlandini
Journal:  Molecules       Date:  2021-10-22       Impact factor: 4.411

Review 9.  Crystallography and Its Impact on Carbonic Anhydrase Research.

Authors:  Carrie L Lomelino; Jacob T Andring; Robert McKenna
Journal:  Int J Med Chem       Date:  2018-09-13

Review 10.  Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Authors:  Cecilia Zavala-Tecuapetla; Manola Cuellar-Herrera; Hiram Luna-Munguia
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.